ELF Beauty Inc (ELF)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $6.98B
Last updated: Nov 17, 2026 at 11:05 AM ET
ELF Beauty Inc (ELF) Stock Forecast
Analysts expect ELF Beauty (ELF) to earn $3.90 per share in the fiscal year ending Mar 31, 2027, on revenue of $2.03B. Of 18 analysts, 12 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 14 estimates for the fiscal year ending Mar 31, 2027 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 18 ratings average 2.28, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 5.6% |
| Buy | 11 | 61.1% |
| Hold | 6 | 33.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 18
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 7.4% and revenue estimates rise 9.4%.
- Fiscal year ending Mar 31, 2027
- $3.90
- EPS consensus, revenue $2.03B
- Fiscal year ending Mar 31, 2028
- $4.19
- EPS consensus, revenue $2.22B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $3.90 | $3.85 to $4.06 | 19 | $2.03B | $2.01B to $2.05B | 18 |
| Mar 31, 2028 | $4.19 | $3.95 to $4.43 | 18 | $2.22B | $2.15B to $2.30B | 18 |
Quarterly Estimates
The EPS consensus falls from $0.76 for the quarter ending Dec 31, 2026 to $0.32 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.76 | $0.57 to $1.06 | 19 | $548.41M | $536.80M to $557.66M | 17 |
| Mar 31, 2027 | $0.32 | -$0.12 to $0.81 | 20 | $490.28M | $462.75M to $563.64M | 18 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 28 upward and 4 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2027 | 14 | 0 |
| Fiscal year ending Mar 31, 2028 | 8 | 1 |
| Quarter ending Dec 31, 2026 | 6 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has risen 8.0% from $3.61.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | $3.90 | $3.66 | $3.63 | $3.61 | $3.61 | +8.1% |
| Fiscal year ending Mar 31, 2028 | $4.19 | $3.96 | $3.87 | $3.83 | $3.84 | +9.1% |
| Quarter ending Dec 31, 2026 | $0.76 | $0.86 | $0.85 | $0.84 | $0.84 | -9.2% |
Frequently Asked Questions About ELF
What is the ELF stock forecast?
Consensus analyst estimates put ELF Beauty's EPS at $3.90 for the fiscal year ending Mar 31, 2027, on revenue of $2.03B. The consensus rating from 18 analysts is Buy.
How do analysts rate ELF stock?
Of 18 analysts covering ELF Beauty, 1 rates it Strong Buy, 11 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ELF next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $3.90, with estimates from $3.85 to $4.06 from 19 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $4.19, with estimates from $3.95 to $4.43 from 18 analysts.
What revenue do analysts expect from ELF Beauty next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $2.03B, with estimates from $2.01B to $2.05B. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $2.22B, with estimates from $2.15B to $2.30B.
How many analysts cover ELF?
18 analysts rate ELF Beauty stock, and 19 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.
ELF pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors